Navigation Links
Consumers Open Up on RealSelf.com About 'Getting Work Done'
Date:10/26/2007

New website allows consumers to share experiences on anti-aging and

personal beauty

SEATTLE, Oct. 26 /PRNewswire/ -- RealSelf.com (http://www.realself.com) today announced the public launch of the first consumer website dedicated to consumer reviews and expert opinions regarding anti-aging products, treatments, and lifestyle choices. On RealSelf.com, consumers engage in an open and honest conversation about important decisions that affect the way they look and feel.

(Photo: http://www.newscom.com/cgi-bin/prnh/20071026/AQF047)

"As consumers search for ways to address the visible signs of aging, they confront a vast range of choices, exaggerated product claims and the social stigma associated with 'getting work done,' " said Tom Seery, president and founder of RealSelf.com. "RealSelf.com helps consumers navigate the anti-aging and personal beauty marketplace by providing access to real-life consumer reviews and answers to important questions from a range of industry experts."

Conversations on RealSelf.com reveal:

-- Hard-to-find consumer insights: RealSelf Consumer Reviews

(http://www.realself.com/reviews) offer real life consumer

assessments of anti-aging solutions from teeth whitening to plastic

surgery, from laser hair removal to wrinkle fillers. Consumers can

gather valuable insights to help them make decisions. "I was ready

to do something about my face wrinkles, but I needed more info than

what I found in pamphlets featuring 20-something models," said Kris

M., who recently authored a review on RealSelf.com. "The real life

experiences described on RealSelf were essential to setting my

expectatio
'/>"/>

SOURCE RealSelf.com
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Identifying What Consumers Look For On Food Stuff Labels
2. Consumers Becoming More Health Conscious Than Calorie Conscious
3. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
4. Consumers of soft drinks to be more alert
5. Consumers Worried About Trans-Fats The Most
6. Chocolate makers to be health wise and urge consumers to be too!
7. Chicken Prices Show an Upward Trend – Consumers, Not Scared Chicken Anymor
8. Singapore Warns Consumers Against Indian Medicine for Treating Piles
9. Consumers way off the mark in measuring calorie content in fast foods
10. Labeling of Dairy Products with Trans fat labels, Misleading to Consumers
11. Consumers, Caregivers Taking Steps to Safer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6JumpStart Invests in Checkpoint Surgical 6118 1JumpStart Invests in Checkpoint Surgical 6118 2JumpStart Invests in Checkpoint Surgical 6118 3Some chest pain patients wait longer than 10 minutes to see ER physician 61033 1Some chest pain patients wait longer than 10 minutes to see ER physician 61033 2Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 6115 1Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 6115 2
Other Medicine Technology:Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9Video: Actress and New Mom Keri Russell Joins PKIDs to Launch 'Silence the Sounds of Pertussis' Campaign 2Video: Actress and New Mom Keri Russell Joins PKIDs to Launch 'Silence the Sounds of Pertussis' Campaign 3